Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · June 27, 2023

Motor, Respiratory, and Bulbar Function 4 Years After Nusinersen Treatment in Patients With Type I Spinal Muscular Atrophy

European Journal of Neurology


Additional Info

European Journal of Neurology
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function
Eur. J. Neurol. 2023 Jun 01;30(6)1755-1763, M Pane, G Coratti, VA Sansone, S Messina, M Catteruccia, C Bruno, M Sframeli, E Albamonte, M Pedemonte, N Brolatti, I Mizzoni, A D'Amico, C Bravetti, B Berti, C Palermo, D Leone, F Salmin, R De Sanctis, MC Pera, M Piastra, O Genovese, F Ricci, I Cavallina, R Masson, R Zanin, C Agosto, E Salomon, I Bruno, A Magnolato, E Bertini, FD Tiziano, F Bovis, E Mercuri

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading